• Please log in or register to access this feature.

Original Article

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network†

  1. Nancy U. Lin MD1,‡,*,
  2. Ann Vanderplas MS2,
  3. Melissa E. Hughes MSc3,
  4. Richard L. Theriault DO, MBA4,
  5. Stephen B. Edge MD, FACS5,
  6. Yu-Ning Wong MD, MSCE6,
  7. Douglas W. Blayney MD7,8,
  8. Joyce C. Niland PhD2,
  9. Eric P. Winer MD1,
  10. Jane C. Weeks MD, MSc1,3

Article first published online: 27 APR 2012

DOI: 10.1002/cncr.27581

Issue

Cancer

Cancer

Volume 118, Issue 22, pages 5463–5472, 15 November 2012

Additional Information

How to Cite

Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., Wong, Y.-N., Blayney, D. W., Niland, J. C., Winer, E. P. and Weeks, J. C. (2012), Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer, 118: 5463–5472. doi: 10.1002/cncr.27581

Author Information

  1. 1

    Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

  2. 2

    Division of Information Sciences, City of Hope Comprehensive Cancer Center, Duarte, California

  3. 3

    Department of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts

  4. 4

    Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  5. 5

    Department of Breast and Soft Tissue Surgery, Roswell Park Cancer Institute, Buffalo, New York

  6. 6

    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

  7. 7

    Department of Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

  8. 8

    Department of Medical Oncology, Stanford University Cancer Center, Palo Alto, California

  1. ‡

    Fax: (617) 632-1930

*Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215

  1. †

    Presented in part at the 45th Annual Meeting of the American Society of Clinical Oncology; May 29 to June 2, 2009; Orlando, FL.

  2. ‡

    Fax: (617) 632-1930

Publication History

  1. Issue published online: 30 OCT 2012
  2. Article first published online: 27 APR 2012
  3. Manuscript Accepted: 2 MAR 2012
  4. Manuscript Revised: 3 FEB 2012
  5. Manuscript Received: 30 NOV 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (218K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K.M. McNamara, T. Yoda, K. Takagi, Y. Miki, T. Suzuki, H. Sasano, Androgen receptor in triple negative breast cancer, The Journal of Steroid Biochemistry and Molecular Biology, 2013, 133, 66

    CrossRef

  2. 2
    Carmen A. Perez, Zachary S. Zumsteg, Gaorav Gupta, Monica Morrow, Brittany Arnold, Sujata M. Patil, Tiffany A. Traina, Mark E. Robson, Yong H. Wen, Beryl McCormick, Simon N. Powell, Alice Y. Ho, Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis, Breast Cancer Research and Treatment, 2013, 139, 2, 497

    CrossRef

  3. 3
    Angela M. Stover, Bryce B. Reeve, Barbara F. Piper, Catherine M. Alfano, Ashley Wilder Smith, Sandra A. Mitchell, Leslie Bernstein, Kathy B. Baumgartner, Anne McTiernan, Rachel Ballard-Barbash, Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study, Quality of Life Research, 2013,

    CrossRef

  4. 4
    Jose M. Pacheco, Feng Gao, Caroline Bumb, Matthew J. Ellis, Cynthia X. Ma, Racial differences in outcomes of triple-negative breast cancer, Breast Cancer Research and Treatment, 2013, 138, 1, 281

    CrossRef

View Full Article (HTML) Get PDF (218K)